US2021212563A1PendingUtilityA1

Integrated medicament delivery device for use with continuous analyte sensor

Assignee: DEXCOM INCPriority: Feb 26, 2004Filed: Mar 30, 2021Published: Jul 15, 2021
Est. expiryFeb 26, 2024(expired)· nominal 20-yr term from priority
A61B 2560/0406A61B 5/0002A61B 5/1486A61M 2205/3592A61M 2230/201A61M 5/31525A61M 2205/3561A61M 2205/50A61B 5/14546A61M 2205/582A61M 5/24A61M 2209/086A61B 2560/0443A61B 2560/04A61M 2205/502A61M 2205/3569A61M 5/003A61B 5/14532A61M 2205/583A61M 5/1723G16H 40/67G16H 20/17A61M 2205/581A61B 2560/0431A61B 5/4839
74
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An integrated system for the monitoring and treating diabetes is provided, including an integrated receiver/hand-held medicament injection pen, including electronics, for use with a continuous glucose sensor. In some embodiments, the receiver is configured to receive continuous glucose sensor data, to calculate a medicament therapy (e.g., via the integrated system electronics) and to automatically set a bolus dose of the integrated hand-held medicament injection pen, whereby the user can manually inject the bolus dose of medicament into the host. In some embodiments, the integrated receiver and hand-held medicament injection pen are integrally formed, while in other embodiments they are detachably connected and communicated via mutually engaging electrical contacts and/or via wireless communication.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method for monitoring and treating diabetes, comprising:
 administering an amount of a medicament into a host;   receiving and processing sensor data from a continuous glucose sensor, wherein the sensor data is indicative of a glucose concentration of the host in vivo; and   inputting host information to a user interface, outputting the sensor data on the user interface, or outputting medicament therapy on the user interface.   
     
     
         2 . The method of  claim 1  wherein the administering is selected from the group consisting of injecting, infusing, causing inhalation or transdermal absorption of the amount of medicament into the host. 
     
     
         3 . The method of  claim 1  further comprising calculating at least one of a time of medicament therapy and an amount of medicament therapy. 
     
     
         4 . The method of  claim 1  further comprising displaying a graphical representation of at least one of sensor data and medicament delivery data, wherein a solid line represents at least one of a target glucose concentration and a range. 
     
     
         5 . The method of  claim 1  wherein the administering is performed by a medicament injection pen or a medicament pump. 
     
     
         6 . The method of  claim 1  wherein the administering is performed by a medicament injection pen and further comprising remotely controlling a rate of medicament injection by the medicament injection pen into the host. 
     
     
         7 . The method of  claim 1  further comprising requiring validation prior to administering the amount of the medicament into the host. 
     
     
         8 . The method of  claim 1  wherein processing the sensor data includes processing the sensor data and generating the medicament therapy. 
     
     
         9 . A method for monitoring and treating diabetes, comprising:
 administering an amount of a medicament into a host;   receiving and processing sensor data from a continuous glucose sensor, wherein the sensor data is indicative of a glucose concentration of the host in vivo; and   requiring validation prior to administering the amount of the medicament into the host.   
     
     
         10 . The method of  claim 9  further comprising inputting host information to a user interface, outputting the sensor data on the user interface, or outputting medicament therapy on the user interface. 
     
     
         11 . The method of  claim 9  wherein the administering is selected from the group consisting of injecting, infusing, causing inhalation or transdermal absorption of the amount of medicament into the host. 
     
     
         12 . The method of  claim 9  further comprising calculating at least one of a time of medicament therapy and an amount of medicament therapy. 
     
     
         13 . The method of  claim 9  further comprising displaying a graphical representation of at least one of sensor data and medicament delivery data, wherein a solid line represents at least one of a target glucose concentration and a range. 
     
     
         14 . The method of  claim 9  wherein the administering is performed by a medicament injection pen or a medicament pump. 
     
     
         15 . The method of  claim 9  wherein the administering is performed by a medicament injection pen and further comprising remotely controlling a rate of medicament injection by the medicament injection pen into the host. 
     
     
         16 . The method of  claim 10  wherein processing the sensor data includes processing the sensor data and generating the medicament therapy.

Join the waitlist — get patent alerts

Track US2021212563A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.